The swine flu might appear to be a business bonanza for makers of flu vaccines, but big profits are far from a sure thing — and production of a vaccine poses some financial risks.
Swine flu could boost some sales for drugmakersCourtesy Newsvine - business Fri, 05/08/2009 - 13:15
The swine flu might appear to be a business bonanza for makers of flu vaccines, but big profits are far from a sure thing — and production of a vaccine poses some financial risks. Related itemsChina set to approve 1-dose swine flu vaccines
Some who get vaccine not in high-risk groups
Japan company sells anti-H1N1 suit
Samsung SCX-4200 3-in-1 True Multifunction Printer
BlueAnt UNOTPBAX53 X5 Bluetooth Stereo Headphone...
|
Post new comment